Sihuan Pharmaceutical Hldgs Watchlist
Sihuan Pharma (460 HK) Denies China Resources Approach
352 Views, 13 May 2022 13:17
Sihuan Pharmaceutical (460 HK) has shot down rumours that it is under negotiation with potential investors in respect of privatisation.
- Reportedly SOE China Resources is in talks with Sihuan Pharma's chairman in a deal valuing the company at US$3bn or a 114% premium to the current price.
- The logic of a privatisation makes sense. I would not be so quick to dismiss the denial. Plus Sihuan Pharma is very cash-rich.